SINGLE NUCLEOTIDE POLYMORPHISMS IN BREAST TUMOR AND EXPRESSION OF ABC-TRANSPORTERS AFTER NEOADJUVANT CHEMOTHERAPY

SINGLE NUCLEOTIDE POLYMORPHISMS IN BREAST TUMOR AND EXPRESSION OF ABC-TRANSPORTERS AFTER NEOADJUVANT CHEMOTHERAPY

The mechanism of regulation of ABC transporter gene expression, which is related to individual characteristics of the tumor-bearing organism and its tumor, defined by gene single nucleotide polymorphisms (SNP – Single Nucleotide Polymorphism) has not been extensively studied. We conducted large-scal...

Full description

Bibliographic Details
Main Authors:	M. M. Tsyganov, M. K. Ibragimova, E. M. Slonimskaya, N. V. Cherdyntseva, N. V. Litviakov
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2016-02-01
Series:	Сибирский онкологический журнал
Subjects:	авс-транспортеры, рак молочной железы, однонуклеотидный полиморфизм, микроматричное исследование
Online Access:	https://www.siboncoj.ru/jour/article/view/154

Similar Items

Gene expression analysis of ABC transporter family in breast tumors: relationship with chemotherapy effect and disease prognosis
by: M. M. Tsyganov, et al.
Published: (2020-09-01)

RELATIONSHIP OF THE IMMUNOLOGICAL PARAMETRES WITH NEOADJUVANT CHEMOTHERAPY EFFECTIVENESS IN BREAST CANCER PATIENTS
by: Y. V. Kukharev, et al.
Published: (2016-02-01)

MOLECULAR-GENETIC MARKERS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY WITH ANTHRACYCLINES IN BREAST CANCER PATIENTS
by: P. V. Kazantseva, et al.
Published: (2016-07-01)

The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients
by: N. N. Babyshkina, et al.
Published: (2020-04-01)

Whole transcriptome analysis of breast tumors during neoadjuvant chemotherapy: association with response to preoperative chemotherapy
by: M. K. Ibragimova, et al.
Published: (2022-03-01)

BRCA1 mRNA expression levels as an predictor of response to neoadjuvant chemotherapy in breast cancer
by: M. M. Tsyganov, et al.
Published: (2018-05-01)

X-ray and ultrasound semiotics of mucinous carcinoma of the breast
by: K. A. Lesko, et al.
Published: (2014-07-01)

MICROARRAY ANALYSIS OF DNA COPY NUMBER ABERRATION IN BREAST TUMOR: CORRELATION WITH THE EFFICACY OF NEOADJUVANT CHEMOTHERAPY
by: N. V. Litviakov, et al.
Published: (2016-02-01)

The role of digital mammography, scintimammography with <sup>99m </sup>Tc-methoxyisobutylisonitrile (MIBI) and ultrasound in the diagnosis of multicentric breast cancer
by: A. V. Chernaya, et al.
Published: (2020-03-01)

Aberrations of the number of copies (CNA) in the genome of luminal B breast tumor
by: M. K. Ibragimova, et al.
Published: (2020-10-01)

ANALYSIS OF ASSOCIATIONS OF VEGF-A GENE POLYMORPHISM AT POSITIONS 2578A/C AND +936C/T WITH DIFFERENT RECEPTOR STATUS IN BREAST CANCER PATIENTS
by: A. V. Shevchenko, et al.
Published: (2016-02-01)

Sonography and mammogram in the diagnosis of mammary cancer developed because of the non-malignant proliferative changes
by: M. A. Tsesarsky, et al.
Published: (2002-06-01)

COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER
by: P. V. Krivorotko, et al.
Published: (2017-12-01)

Occult breast cancer. Literature review and case series
by: О. S. Khodorovich, et al.
Published: (2021-03-01)

Relation of EGFR/PI3K/AKT signaling components with tamoxifen efficacy in patients with estrogen-dependent breast cancer
by: T. A. Dronova, et al.
Published: (2018-11-01)

Neoadjuvant treatment for breast cancer
by: V. F. Semiglazov, et al.
Published: (2014-07-01)

Features of ultrasound of endometrial pathological conditions in breast cancer patients receiving tamoxifen: a review of literature
by: M. A. Chekalova, et al.
Published: (2020-06-01)

Hereditary breast cancer: genetic and clinical hetergeneity, genetic testing, prophylactic surgery
by: L. N. Lyubchenko, et al.
Published: (2015-06-01)

The role of neoadjuvant chemotherapy of triple-negative breast cancer in St. Petersburg City Clinical Oncological Dispensary
by: A. G. Manikhas, et al.
Published: (2016-09-01)

Phenomenon of loss of heterozygosity in tumour tissue of breast cancer: association with expression of monoresistance genes
by: M. M. Tsyganov, et al.
Published: (2018-01-01)

Gradient phenomenon of multidrug resistance gene expression in breast cancer during neoadjuvant chemotherapy is related to disease progression
by: N. V. Litviakov
Published: (2016-02-01)

ROLE OF TRANSFORMING GROWTH FACTOR RECEPTOR B I TYPE (TGF-BRI) IN THE PROGRESSION OF THE LUMINAL BREAST CANCER SUBTYPE
by: N. N. Babyshkina, et al.
Published: (2017-06-01)

EXPRESSION of MACROPHAGe-ASSOCIATED GENES IN BREAST TUMORS: RELATION TO TUMOR PROGRESSION
by: N. V. Litviakov, et al.
Published: (2017-12-01)

IMMEDIATE RESPONSE TO NEOADJUVANT CHEMOTHERAPY INCLUDING CAPECITABINE AND LONG-TERM TREATMENT OUTCOMES OF OPERABLE BREAST CANCER
by: E. M. Slonimskaya, et al.
Published: (2016-07-01)

The ultrasound screening of the benign breast diseases and breast cancer
by: N. A. Zakharova
Published: (2015-01-01)

The influence of functional skewness on prognosis of cancer of mammary gland
by: L. E. Erendeeva, et al.
Published: (2002-03-01)

Predictive and prognostic significance of loss of heterozygosity in ABC transporter genes in breast cancer
by: M. M. Tsyganov, et al.
Published: (2022-11-01)

Ultrasonic, hysteroscopic and histological evaluation of the endometrium in women receiving tamoxifen for breast cancer
by: N. S. Melnikova, et al.
Published: (2014-07-01)

Strategy of post-neoadjuvant treatment of patients with residual breast cancer
by: V. V. Semiglazov, et al.
Published: (2020-06-01)

RISK FACTORS FOR RENAL CELL CARCINOMA
by: D. G. Zaridze, et al.
Published: (2018-11-01)

Breast cancer radiology in women with hypothyroidism
by: S. K. Ternovoy, et al.
Published: (2014-07-01)

Impact of various options of neoadjuvant chemotherapy on the hormonal status of patients with breast cancer
by: Yu. S. Sidorenko, et al.
Published: (2014-08-01)

Evaluation of the scientific results of the study entitled “Opportunities for surgical treatment of patients with stage IV breast cancer” performed by Russian Society of Oncomammologists (RSOM)
by: A. A. Bozhok, et al.
Published: (2017-02-01)

Vacuum-assisted aspiration biopsy in mammology practice. Analysis of 3-year experience
by: S. S. Skurikhin, et al.
Published: (2020-11-01)

MEDULLARY CARCINOMA OF THE BREAST: ROENTGENOLOGIC AND ULTRASOUND SEMIOTICS
by: A. B. Abduraimov, et al.
Published: (2015-04-01)

HETEROGENENOUS EXPRESSION OF MARKERS ASSOCIATED WITN INVASIVE BREAST CANCER
by: N. V. Krakhmal, et al.
Published: (2016-10-01)

MOLECULAR-GENETIC AND SERUM DISORDERS MARKERS OF FOLATE METABOLISM IN PATIENTS PROLIFERATIVE DISEASE AND BREAST CANCER
by: A. V. Markovsky, et al.
Published: (2017-06-01)

CORRELATION BETWEEN CHEMOTHERAPY RESPONSE AND EXPRESSION PROFILES OF TRANSMEMBRANE PROTEINS: P-GLYCOPROTEIN (ABCB1), MRP2 (ABCC2), BCRP (ABCG2) IN PATIENTS WITH INVASIVE BREAST CANCER
by: К. Yu. Khristenko, et al.
Published: (2016-10-01)

ASSOCIATION OF THE COMBINATION OF STEMNESS GENE AMPLIFICATIONS AND COPY NUMBER ABERRATIONS OF WNT-SIGNALING GENES IN BREAST TUMORS WITH METASTASIS
by: N. V. Litviakov, et al.
Published: (2020-07-01)

Predictive Significance of Vascular Endothelial Growth Factor receptor VEGF-2 in triple-negative breast cancer patients
by: N. N. Babyshkina, et al.
Published: (2016-11-01)